NCT00368459View on ClinicalTrials.gov

Raloxifene for Women With Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

January 31, 2012

Conditions
Alzheimer Disease
Interventions
DRUG

raloxifene

Raloxifene is a selective estrogen receptor modulator

DRUG

Placebo

Identical appearing placebo

Trial Locations (4)

46202

Indiana University Medical Center, Indianapolis

62794

Southern Illinois University School of Medicine, Springfield

94305

Stanford University School of Medicine, Stanford

95403

Kaiser Permanente Santa Rosa, Santa Rosa

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

Indiana University

OTHER

collaborator

Southern Illinois University

OTHER

lead

Stanford University

OTHER

NCT00368459 - Raloxifene for Women With Alzheimer's Disease | Biotech Hunter | Biotech Hunter